首頁 > 市場調查報告書 > 醫療設備

眼科設備手術用器具

市場調查報告書

商品編碼

1569464

青光眼手術設備市場規模、佔有率和成長分析：按產品、手術方法、最終用途、地區 - 產業預測，2024-2031 年

Glaucoma Surgery Devices Market Size, Share, Growth Analysis, By Product, By Surgery Method, By End-use, By Region - Industry Forecast 2024-2031

出版日期: 2024年10月08日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年青光眼手術設備的全球市場規模為14億美元，從2023年的14.7億美元成長到2031年的21.2億美元，並且預計在預測期內（2024-2031年）複合年成長率為4.70%。

青光眼手術器械市場有望顯著成長，這主要是由於全球青光眼盛行率不斷上升，特別是在人口老化中。隨著這種眼科疾病率的增加，對有效手術介入措施的需求也在增加，手術技術的進步顯著提高了成功率和安全性。人們觀察到微創青光眼手術 (MIGS) 發生了重大轉變，青光眼引流系統和雷射設備等設備由於併發症發生率較低和患者治療效果改善而越來越受歡迎。微創手術的趨勢以小梁微旁路支架和脈絡膜上分流術等技術為特色，透過促進與白內障手術的聯合干預，同時縮短恢復時間，正在徹底改變市場。患者和醫療保健提供者對青光眼早期檢測和早期療育重要性的認知不斷提高，進一步推動了市場的採用。此外，有利的報銷制度正在支持市場擴張，特別是在北美和歐洲等新興市場。隨著強調以患者為中心的護理以促進更好的手術結果，MIGS 的採用不斷增加，並成為成長的關鍵驅動力。根據預測，美國青光眼手術器械市場預計在接下來的預測期內將保持健康的複合年成長率，凸顯了該行業的未來性。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Alcon, Inc.（Switzerland）
Glaukos Corporation（US）
Johnson & Johnson Vision（US）
ASICO, LLC（US）
Carl Zeiss Meditec AG（Germany）
Ziemer Ophthalmic Systems AG（Switzerland）
Iridex Corporation（US）
Altomed（UK）
New World Medical, Inc.（US）
Ellex Medical Lasers Ltd.（Australia）
Topcon Corporation（Japan）
BVI Medical, Inc.（US）
MicroSurgical Technology（MST）（US）
Molteno Ophthalmic Ltd.（New Zealand）
OptoMedica Corporation（US）
iStar Medical SA（Belgium）
NeoMedix Corporation（US）
Sight Sciences, Inc.（US）
Aquesys, Inc.（US）
IOP Ophthalmics（US）
Katena Products, Inc.（US）

簡介目錄

Product Code: SQMIG35A2402

Global Glaucoma Surgery Devices Market size was valued at USD 1.40 billion in 2022 and is poised to grow from USD 1.47 billion in 2023 to USD 2.12 billion by 2031, growing at a CAGR of 4.70% during the forecast period (2024-2031).

The glaucoma surgery devices market is on the brink of significant growth, primarily fueled by the escalating global incidence of glaucoma, particularly among the aging population. As the prevalence of this eye condition rises, the demand for effective surgical interventions is also increasing, supported by advancements in surgical techniques that have markedly improved success rates and safety profiles. A notable shift toward minimally invasive glaucoma surgery (MIGS) has been observed, with devices like glaucoma drainage systems and laser equipment gaining popularity for their reduced complication rates and enhanced patient outcomes. The trend toward less invasive procedures, characterized by techniques such as trabecular micro-bypass stents and suprachoroidal shunts, is revolutionizing the market, allowing for shorter recovery periods while facilitating combined interventions with cataract surgeries. Increased awareness among patients and healthcare providers about the critical importance of early glaucoma detection and intervention further drives market adoption. Additionally, favorable reimbursement frameworks, especially in developed regions like North America and Europe, bolster market expansion. With a heightened emphasis on patient-centered care that promotes better surgical outcomes, the adoption of MIGS is set to continue its upward trajectory, making it a pivotal driver of growth. According to projections, the US glaucoma surgery devices market is anticipated to sustain a healthy compound annual growth rate (CAGR) in the upcoming forecast period, underscoring the promising future of this sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the global glaucoma surgery devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

global glaucoma surgery devices Market Segmental Analysis

Global Glaucoma Surgery Devices Market is segmented by Product, Surgery Method, End-use, and region. Based on Product, the market is segmented into Glaucoma Drainage Device, Traditional Surgery Devices, Diamond Knives, Laser Systems, and Others. Based on Surgery Method, the market is segmented into Traditional Glaucoma Surgery, Minimal Invasive Glaucoma Surgery, and Laser Surgery. Based on End-use, the market is segmented into Hospitals, Ophthalmic Clinics, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the global glaucoma surgery devices Market

The global glaucoma surgery devices market is significantly driven by the aging population and a rise in lifestyle-related factors, including prolonged screen time and an increase in diabetes prevalence, which contribute to a higher incidence of glaucoma. This escalating prevalence necessitates effective surgical interventions, thus intensifying the demand for advanced glaucoma surgery devices. Additionally, heightened awareness among healthcare providers and patients regarding the critical importance of early detection and timely treatment of glaucoma amplifies this market growth. As the healthcare landscape continues to evolve, the pressing need for innovative surgical solutions to combat glaucoma will further bolster the market's expansion.

Restraints in the global glaucoma surgery devices Market

The global glaucoma surgery devices market faces a significant restraint due to the high cost associated with surgical procedures. Factors including the necessity for advanced, specialized equipment, the requirement for highly skilled healthcare providers, and comprehensive post-operative care contribute to increased expenses. Additionally, the cost of the devices themselves adds to the financial burden, making glaucoma surgeries unaffordable for many patients, particularly in developing regions or among those lacking sufficient insurance coverage. This economic barrier not only restricts patient access to essential surgical interventions but also hampers the overall growth potential of the glaucoma surgery devices market.

Market Trends of the global glaucoma surgery devices Market

The global glaucoma surgery devices market is witnessing a significant trend towards combination therapies, which integrate various treatment modalities to optimize intraocular pressure (IOP) management. This approach enhances therapeutic outcomes by leveraging the synergistic effects of medications, laser treatments, and surgical techniques. The emergence of advanced glaucoma devices that incorporate drug-delivery systems, such as sustained-release implants, exemplifies this trend, allowing for targeted and controlled drug administration alongside surgical interventions. As healthcare providers increasingly adopt these innovative solutions, the market is positioned for robust growth, driven by the demand for more effective and personalized glaucoma treatment options.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Value Chain Analysis
Ecosystem of the Market
Case study Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Glaucoma Surgery Devices Market by Product

Market Overview
Glaucoma Drainage Device
- Valves
- Glaucoma Drainage Implant
- Glaucoma Tube Shunts
- Stents
Traditional Surgery Devices
- Scalpel
- Forceps
- Ophthalmic Scissors
- Punch
- Sutures
- Surgical Drapes
- Microcatheter
- Others
Diamond Knives
Laser Systems
Others

Glaucoma Surgery Devices Market by Surgery Method

Market Overview
Traditional Glaucoma Surgery
- Trabeculectomy
- Tube Shunt Surgery
Minimal Invasive Glaucoma Surgery
- Trabecular Meshwork Bypass
- Suprachoroidal Space Implants
- Subconjunctival Space Implants
- Schlemm's Canal Implants
- Gonioscopy-assisted Transluminal Trabeculectomy
- Endocyclophotocoagulation
Laser Surgery
- Trabeculoplasty
- Iridotomy
- Cyclophotocoagulation

Glaucoma Surgery Devices Market by End-use

Market Overview
Hospitals
Ophthalmic Clinics
Others

Glaucoma Surgery Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Alcon, Inc. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Glaukos Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson Vision (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ASICO, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Carl Zeiss Meditec AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ziemer Ophthalmic Systems AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Iridex Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Altomed (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
New World Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ellex Medical Lasers Ltd. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Topcon Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BVI Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroSurgical Technology (MST) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molteno Ophthalmic Ltd. (New Zealand)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OptoMedica Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
iStar Medical SA (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeoMedix Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sight Sciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aquesys, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IOP Ophthalmics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Katena Products, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments